Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Equity: 2009-2025

Historic Return on Equity for Amicus Therapeutics (FOLD) over the last 15 years, with Sep 2025 value amounting to -0.06%.

  • Amicus Therapeutics' Return on Equity rose 61.00% to -0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.06%, marking a year-over-year increase of 61.00%. This contributed to the annual value of -0.32% for FY2024, which is 75.00% up from last year.
  • According to the latest figures from Q3 2025, Amicus Therapeutics' Return on Equity is -0.06%, which was up 66.22% from -0.19% recorded in Q2 2025.
  • Amicus Therapeutics' Return on Equity's 5-year high stood at -0.06% during Q3 2025, with a 5-year trough of -1.85% in Q4 2022.
  • Moreover, its 3-year median value for Return on Equity was -0.91% (2024), whereas its average is -0.84%.
  • Per our database at Business Quant, Amicus Therapeutics' Return on Equity slumped by 112bps in 2022 and then skyrocketed by 86bps in 2025.
  • Amicus Therapeutics' Return on Equity (Quarterly) stood at -0.73% in 2021, then plummeted by 112bps to -1.85% in 2022, then soared by 82bps to -1.03% in 2023, then surged by 73bps to -0.30% in 2024, then soared by 61bps to -0.06% in 2025.
  • Its Return on Equity was -0.06% in Q3 2025, compared to -0.19% in Q2 2025 and -0.15% in Q1 2025.